Autoimmune disease companies develop therapies, diagnostics and research technologies for conditions in which the immune system attacks the body’s own cells and tissues. Their work spans disease detection, immune modulation and the development of more targeted treatments.
This category includes companies working on:
Browse 58 UK autoimmune disease companies below.
Multispecific immune cell engagers targeting gamma delta T cells
Cytospire Therapeutics is developing multispecific engager antibodies designed to enhance and direct the activity of gamma delta T cells for the treatment of cancer and autoimmune…
Probiotic microbiome platform for skin health and dermatological conditions
SkinBioTherapeutics is a biotechnology company developing microbiome-based technologies for skin health. Its proprietary platform harnesses lysates derived from probiotic bacteria…
TCR-based bispecific therapeutics for cancer and autoimmune disease
T-Therapeutics is a biotechnology company developing T cell receptor-based therapeutics for cancer and autoimmune disease. Using a humanised TCR mouse platform to generate…
Programmable iPSC cell therapies for cancer and autoimmunity
Xap Therapeutics is a Cambridge-based biotechnology company developing a synthetic biology platform for next-generation cell therapeutics. The company applies CRISPR technology to…
Oral delivery platform for biologics targeting inflammatory diseases
Intract Pharma is a biotechnology company developing proprietary formulation platforms for the oral delivery of complex biologics including monoclonal antibodies and proteins. The…
Shark-derived single-domain antibody biologics for cancer and inflammation
Elasmogen is a biotechnology company developing next-generation therapeutic biologics based on its proprietary soloMER platform, single-domain antibody-like proteins derived from…
Academic drug discovery accelerator developing small molecule therapeutics
Slingshot Therapeutics is a drug discovery accelerator that identifies early-stage scientific programmes from academic institutions and advances them towards clinical development.…
TCR therapeutic discovery platform targeting solid tumours
T-Cypher Bio is a pre-clinical biotechnology company developing T-cell receptor therapeutics using its proprietary platform, which integrates immunopeptidomics, bead-display…
Small molecule theranostics to improve transplant outcomes
Kairos Biotech is an early-stage biotechnology company developing proprietary small molecules and nanoscale-engineered binders for application in transplant diagnostics and…
Dark genome platform identifying first-in-class targets for autoimmune disease
Nucleome Therapeutics is a drug discovery company using 3D genome mapping to identify therapeutic targets encoded in the non-coding regions of the human genome. Its platform…